Text Size
2 studies found for:    12682882 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b
2 Recruiting Combination Therapy for Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Fixed Dose GS-7977/GS-5885;   Drug: GS-7977 + GS-9669
To Top

† Indicates status has not been verified in more than two years